Mario Del Tacca

Medicine · Health Sciences

56h-index9.8kcitations502works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Helicobacter pylori-related gastroenterology studies(55), Cancer Treatment and Pharmacology(54), Gastrointestinal motility and disorders(44), Neuropeptides and Animal Physiology(43), Cancer therapeutics and mechanisms(38)

Publications501 total

Supplementary Fig. S1 from Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines
2023Open Access
Data from Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines
2023Open Access
Supplementary Fig. S1 from Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines
2023Open Access
Data from Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines
2023Open Access
Effects of Octreotide on Angiogenesis
Progress in basic and clinical pharmacology·2015· 9 cited
Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers
Therapeutics and Clinical Risk Management·2013· 6 citedOpen Access
Clinical Pharmacokinetics of Antibacterials in Cerebrospinal Fluid
Clinical Pharmacokinetics·2013· 47 cited
Contents
Lung Cancer·2011Open Access
Antinflammatory therapy and cardiovascular risk: a consensus view
Reumatismo·2011Open Access
The Emerging Role of Sunitinib in the Treatment of Advanced Epithelial Thyroid Cancer: Our Experience and Review of Literature
Mini-Reviews in Medicinal Chemistry·2011· 7 cited
Linezolid in the central nervous system: Comparison between cerebrospinal fluid and plasma pharmacokinetics
Scandinavian Journal of Infectious Diseases·2011· 24 cited
Synergistic cytotoxicity, inhibition of signal transduction pathways and pharmacogenetics of sorafenib and gemcitabine in human NSCLC cell lines
Lung Cancer·2011· 29 cited
Time‐Dependent Pharmacokinetics of 5‐Fluorouracil and Association With Treatment Tolerability in the Adjuvant Setting of Colorectal Cancer
The Journal of Clinical Pharmacology·2011· 13 cited
Irinotecan Synergistically Enhances the Antiproliferative and Proapoptotic Effects of Axitinib In Vitro and Improves Its Anticancer Activity In Vivo
Neoplasia·2011· 39 citedOpen Access
Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer
British Journal of Cancer·2011· 60 citedOpen Access
C11 Cytotoxic drugs
Birkhäuser Basel eBooks·2011
34 AZD1152 PLUS GEMCITABINE FOR PANCREAS CANCER TREATMENT: IN VITRO AND IN VIVO STUDY
Cancer Treatment Reviews·2010
Differential recruitment of high affinity A1 and A2A adenosine receptors in the control of colonic neuromuscular function in experimental colitis
European Journal of Pharmacology·2010· 44 cited
Esomeprazole-induced hyperchromograninemia in the absence of concomitant hypergastrinemia
Nature Reviews Gastroenterology & Hepatology·2010· 3 cited
Pharmacological Issues of Linezolid
Clinical Pharmacokinetics·2010· 81 cited
page 1 of 26Next →

Frequent Co-authors

Romano Danesi(28), Corrado Blandizzi(18), Guido Bocci(12), Rocchina Colucci(12), Antonello Di Paolo(11), Alfredo Falcone(9), Matteo Fornai(9), Pierfranco Conté(8), Elisa Giovannetti(6), Valentina Mey(6), Giacomo Allegrini(6), Luca Antonioli(6), Sara Nannizzi(4), Cinzia Orlandini(4), Stefano Fogli(4), Alessandra Gennari(4), Giuseppe Pasqualetti(4), Gianluca Masi(4), Narcisa Ghisu(4), Marco Tuccori(4)